Baird Maintains Neutral on Bio-Techne, Raises Price Target to $73

Benzinga Newsdesk www.benzinga.com Neutral 48.5%

Neg 0% Neu 48.5% Pos 0%

Baird analyst Catherine Schulte maintains Bio-Techne (NASDAQ:TECH) with a Neutral and raises the price target from $49 to $73.